• KYODO

  • SHARE

U.S. pharmaceutical company Johnson & Johnson said Monday it had filed for Japanese health ministry approval of its coronavirus vaccine through its local unit.

If approved, the firm said its vaccine could be delivered to Japan in early 2022, becoming the fourth vaccine in the fight against COVID-19 in the country, which is lagging behind other nations in its vaccine rollout.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)